Comparative Analysis of Drug Information Resources for Dose Adjustment in terms of Renal and Hepatic Function
![]() |
Ryu, Ji Hyeon
(Department of Pharmacy, St. Mary's Hospital)
Kyoung, Eun Jung (College of Pharmacy, Chungnam National Univ.) Lee, Hee Young (College of Pharmacy, Chungnam National Univ.) Oh, Mina (Department of Pharmacy, St. Mary's Hospital) Kim, Eun Young (College of Pharmacy, Chungnam National Univ.) |
1 | RK Verbeeck, FT Musuamba. Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol. 2009; 65: 757-773. DOI ScienceOn |
2 | SK Swan, WM Bennett. Drug dosing guidelines in patients with renal failure. West J Med. 1992; 156: 633-638. |
3 | KR Verbeeck. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008; 64: 1147-1161. DOI ScienceOn |
4 | Reichen J. Prescribing in liver disease. J Hepatol. 1997; 26: 36-40. DOI |
5 | Huet PM, Villeneuve JP. Determinants of drug disposition in patients with cirrhosis. Hepatology. 1983; 3: 913-918. |
6 | HK Cha, HS Gwak. The effects of liver disease on Amikacin-induced nephrotoxicity, J. Kor. Soc. Health-Syst. Pharm., 2008; 25: 152-158. |
7 | JM Oh. The Development of Medication Management Guidelines for Patients with Disease Contraindication. Korea Food & Drug Administration, 2007. p. 64-66 |
8 | L Vidal, M Shavit, A Fraser, et al., Systematic comparison of four sources of drug information regarding adjustment of dose for renal function. BMJ. 2005; 331: 263-267 DOI ScienceOn |
9 | Korean National Formulary. Korea Food & Drug Administration, 2011. http://ezdrug.kfda.go.kr/kfda2/ |
10 |
GK McEvoy, J Miller, EK Snow, et al., American Hospital (AHFS) drug |
11 |
|
12 | GR Aronoff, B JS erns, ME Brier, et al., Drug prescribing in renal failure: dosing guidelines for adults and children. Philadelphia: American College of Physicians, 2007. |
13 | Information Report of Right Drug Use for Patient with Renal Disease : for expert. Korea Food & Drug Administration 2011. p412-415 |
14 | Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Updated January 10, 2011. |
15 | T Baba, S Murabayashi, T T omiyama, et al., The pharmacokinetics of enalapril in patients with compensated liver cirrhosis. Br J Clin Pharmacol. 1990; 29:766-769. DOI ScienceOn |
16 | SJ Kim, JM Oh, and HT Shin. A Comparative Evaluation of Drug Information Databases in Korea. Kor. J. Clin. Pharm. 2011; 11:30-41. |
![]() |